TrialNeuro-oncology2015

Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.

Marta Penas-Prado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.